Dr Reddy's Q3 profit tumbles, hit by U.S. pricing pressure

Indian generic drugmaker Dr Reddy's Laboratories Ltd posted a 38.5 percent slump in quarterly net profit as sales declined due to pricing pressure in the United States, its biggest market.

Published: 25th January 2018 12:13 PM  |   Last Updated: 25th January 2018 12:32 PM   |  A+A-

Image for representational purpose only.

By Reuters

REUTERS: Indian generic drugmaker Dr Reddy's Laboratories Ltd said quarterly net profit slumped nearly 40 percent, its third consecutive quarter of declines as pricing pressures in the United States hit sales.

Indian drugmakers have faced challenges in negotiating prices as a result of consolidation among drug distributors in the United States, the world's biggest pharmaceuticals market. Like many of its domestic rivals, Dr Reddy's has also been hit by U.S. bans on Indian plants over quality control issues.

Net profit fell 38.5 percent to 3.03 billion rupees ($47.7 million) in the third quarter ended Dec. 31, below an average analyst estimate of 3.4 billion rupees.

Revenue from the company's generics business in North America fell 3 percent to 16.07 billion rupees.

Revenue from its Europe generics business dropped 7 percent to 2.01 billion rupees due to pricing pressures and temporary disruptions in supply.

Dr Reddy's shares fell as much as 3.5 percent to 2,469 rupees in a broader Mumbai market that was trading down 0.3 percent.

Stay up to date on all the latest Business news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp